vTv Therapeutics (VTVT) Other Non Operating Income (2014 - 2026)

vTv Therapeutics has disclosed Other Non Operating Income across 11 years of filings, most recently posting $24000.0 for Q1 2026.

• Other Non Operating Income for Q1 2026 came in at $24000.0, up 241.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $2000.0 (up 101.69% YoY), and the FY2025 annual result was -$109000.0, up 27.33% from the prior year.
• Other Non Operating Income came in at $24000.0 for Q1 2026 at vTv Therapeutics, up from -$70000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $725000.0 in Q4 2022 to a low of -$3.6 million in Q3 2023.
• The 5-year median for Other Non Operating Income is -$6000.0 (2025), against an average of -$392588.2.
• Peak annual rise in Other Non Operating Income reached 471.7% in 2023, while the deepest fall reached 1023.46% in 2023.
• vTv Therapeutics' Other Non Operating Income stood at $725000.0 in 2022, then tumbled by 76.83% to $168000.0 in 2023, then sank by 282.74% to -$307000.0 in 2024, then surged by 77.2% to -$70000.0 in 2025, then jumped by 134.29% to $24000.0 in 2026.
• The last three Other Non Operating Income figures came in at $24000.0 (Q1 2026), -$70000.0 (Q4 2025), and -$6000.0 (Q3 2025), per Business Quant data.